Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gene therapy -- Ignore unavailable to you. Want to Upgrade?

To: mike head who wrote (150)	9/7/1999 10:40:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 319

Mike: Please don't misunderstand...... this was a 1988 perspective, with a little bit of 90's absorption thrown in. Lots of the confusing stuff that I was talking about has certainly been resolved. I was so sick of therapeutic monoclonals at the turn of the decade that I've only recently begun to look again. Just joined the PDLI yahoo club.... thanks for the pointer, Gordon. Rick

To: mike head who wrote (150)	9/7/1999 11:16:00 PM
From: Gordon James	Respond to of 319

Mike, Ah, you already know about the club, good. Figured that given your interest in this topic, you would like it (hate to put in plugs for competing discussion sites hereabouts, but figured I'd make an exception given the quality of this particular one). This antibody patent stuff is indeed a convoluted business! Can't say that I understand it very well either (haven't spent much time digging into it), except for the general notion that PDLI should get money from people doing humanized MAbs, Celltech should get it from people doing chimerized, etc... Gordon